News Releases


Coveted NCI award comes to Sung, UT Health San Antonio

September 17, 2019
 

UT Health San Antonio biochemist Patrick Sung, D.Phil., one of the world’s leading experts on BRCA1 and BRCA2 cancer biology, has just received a highly competitive National Cancer Institute (NCI) Outstanding Investigator Award. Dr. Sung is the first faculty member in UT Health San Antonio history to capture this prestigious NCI award, which is bestowed […]

Read more



Rockwood honored as an AOA Pillar of the Orthopaedic Profession

September 13, 2019
 

Charles A. Rockwood, Jr., M.D., FAOA, of UT Health San Antonio has been honored by the American Orthopaedic Association as an AOA Pillar of the Orthopaedic Profession for his tremendous contributions to orthopaedic surgery. The effort to recognize Dr. Rockwood was led by Bernard F. Morrey, M.D., FAOA, with the generous support of many colleagues, […]

Read more



Noted heart failure expert to join UT Health San Antonio

September 10, 2019
 

UT Health San Antonio has recruited Allen S. Anderson, M.D., FACC, FAHA, to direct and expand the university’s many initiatives in cardiology and cardiovascular disease education and research. Dr. Anderson is a nationally recognized leader in heart failure and cardiac transplantation at the Northwestern University Feinberg School of Medicine in Chicago. On Nov. 1, he […]

Read more


Stroke

Study identifies easier way to assess what stroke does to the brain

September 9, 2019
 

Highlights: A small genetic “fingerprint,” known as a microRNA, was linked with stroke and the long- term effects of stroke on your body. MicroRNA levels can be measured from a simple blood test, creating the opportunity for a more affordable and more practical option than examining actual brain tissue or using other conventional tests. MicroRNAs […]

Read more



FDA approves new MPN drug that Mays Cancer Center director helped develop

September 9, 2019
 

SAN ANTONIO (Sept. 9, 2019)  ̶  September is Blood Cancer Awareness Month, and this year patients with myelofibrosis, a rare blood cancer, have reason to celebrate. In mid-August, the U.S. Food and Drug Administration approved the first new medication in nearly a decade for patients with myelofibrosis. Ruben Mesa, M.D., FACP, was part of the […]

Read more



Salud America! launches health equity podcast

September 3, 2019
 

By Josh McCormack, Institute for Health Promotion Research, UT Health San Antonio On Sept. 3, Salud America!, a national communication organization focused on driving community change for the health of Latino and all families, announced its newest project: the “Salud Talks” podcast. This weekly production aims to expand the health equity conversation by approaching each […]

Read more